Financials
Financial year 2025
COOPS Med from Antwerpen, company number BE1017362724, closed financial year 2025 with a result of € 0 after tax. For that financial year COOPS Med recorded a gross margin of € 379,075 and equity of € 2,100. Around break-even. The company holds a healthy buffer. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 2,100
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 0
Profit after tax over the fiscal year.
€ 739,900
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 0.
People and assets in 2025
4.9
Average over the fiscal year, from the social balance sheet.
€ 365,988
€ 74,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.3 million
Supplier invoices still open on the last day of the fiscal year.
€ 36,746
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
What happened to COOPS Med?
What happened at COOPS Med in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 0. Source: NBB ↗
- New establishment in Antwerpen. KBO
- Dries Opsomer became a director. NBB
- Steven Colpaert became a director. NBB
- Start of the company according to the CBE. KBO
In short
Paid € 220 in corporate taxes since 2025.
On average € 77,400 of value added per employee in 2025.
A new publication or filing at COOPS Med? We notify you, reason included.
Follow COOPS MedDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of VC Zorg, DR. DRIES OPSOMER comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
COOPS MedBehind COOPS Med are Dries Opsomer and Steven Colpaert. The shares are held by VC Zorg (100%) and DR. DRIES OPSOMER (50%).
Directors
According to the 2025 annual accounts
Dries Opsomer
Director
since 2024
since 2024
Shareholders
100%
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Lange Leemstraat 9a
2018 Antwerpen
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 1017.362.724
- VAT number
- BE 1017.362.724
- Registered office
- Lange Leemstraat 9a, 2018 Antwerpen
- Names & denominations
- COOPS Med
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 13 December 2024
- Peppol
- Active · Active since 4 Aug 2025
- Activities · NACE
Activiteiten van medisch specialisten